Riskpilot← Back to searchSign inGet full accessEsperante AB
ABActiveOrg 5566826854Economic activity was not specified by tax authority · NACE 0000Est. 20050 employees
Revenue 2024
SEK 0
EBITDA margin
—
-6% vs 2023
Equity ratio
10.1%
Financial strength
Net profit 2024
SEK -1,1M
+77% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -447K | -6% |
| Net profit | SEK -1,1M | +77% |
| Total assets | SEK 51,5M | -23% |
| Equity | SEK 5,2M | +920% |
| Employees | 0 | — |
Legal name
Esperante AB
Org number
5566826854
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
1 juli 2005
Share capital
SEK 126 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska förvärva och förvalta andelar i bolag verksamma inom hälsovårdsindustrin samt ävensom bedriva annan därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −140 | −185 | −314 | −422 | −447 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −140 | −185 | −314 | −422 | −447 |
| Net financials | −180 | −42 313 | −70 788 | −6 712 | −3 173 |
| Profit before tax | −321 | −21 515 | −6 682 | −4 549 | −1 054 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −321 | −21 515 | −6 682 | −4 549 | −1 054 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 48 395 | 32 001 | 29 539 | 67 175 | 51 474 |
| Equity | 31 668 | 10 835 | 5 076 | 510 | 5 202 |
| Long-term debt | 16 607 | 20 572 | 24 093 | 53 549 | 45 595 |
| Short-term debt | 110 | 595 | 367 | 13 115 | 676 |
| Total debt | 16 717 | 21 167 | 24 460 | 66 664 | 46 271 |
EBITDA margin
-44700000.0%
This company
15.8%
Market median
-282911492% vs market
20202024
Equity ratio
10.1%
This company
38.2%
Market median
-74% vs market
20202024
Return on equity
-20.3%
This company
18.4%
Market median
-210% vs market
20202024
Net profit margin
-105400000.0%
This company
8.1%
Market median
-1301234668% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
8.90×
This company
0.62×
Market median
-1335% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SE Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
SJ Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ESPERANTE VENTURES B.V
Esperante AB (this company)Board members of Esperante AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Elisabet Königslehner | Chief Auditor | 0 companies |
| Sven Jakob Tenselius | Chief Auditor | 0 companies |
| Dean Marc Slagel | Board of Directors | 0 companies |
| Jeffrey David Hobbs | Chairman | 0 companies |
| Lars-Göran Peter Nilsson | Board of Directors | 0 companies |